(Q40659460)

English

Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate

scientific article published on March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Liposome-mediated targeting of enzymes to cancer cells for site-specific activation of prodrugs: comparison with the corresponding antibody-enzyme conjugate (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Hidde J. Haisma

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

María José Fonseca

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Joycelyn C Jagtenberg

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Gert Storm

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Pharmaceutical Research

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

423-428

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of immuno-enzymosomes with maximum enzyme targeting capability: effect of the enzyme density on the enzyme targeting capability and cell binding properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of novel anthracycline prodrugs activated by human beta-glucuronidase for use in antibody-directed enzyme prodrug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of immunoliposomes directed against human ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12669963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1022608321861

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40659460&oldid=1904265029"